Stocktoria
GE HealthCare Technologies Inc. GEHC
GE HealthCare Technologies Inc. (GEHC) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the grey zone. It pays a dividend yielding 0.21% (safety: safe). FY2025 revenue was $20.6B at a 10.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-07-31 | UBS | Neutral (main) |
| 2026-07-30 | Citigroup | Neutral (main) |
| 2026-07-30 | Evercore ISI Group | Outperform (main) |
| 2026-07-30 | Wells Fargo | Overweight (main) |
| 2026-07-29 | BTIG | Buy (main) |
| 2026-07-17 | Hovde Group | Market Perform (init) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Forward estimates · earnings calendar →
Consensus analyst estimates and scheduled dates — forward-looking, may change.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · grey zone
| Component | Value |
|---|---|
| Working capital / assets | 0.092 |
| Retained earnings / assets | 0.143 |
| EBIT / assets | 0.075 |
| Equity / liabilities | 0.395 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| GEHC | GE HealthCare Technologies Inc. | 4/9 | 1.99 | 14.4 | +4.8% |
| BFLY | Butterfly Network, Inc. | 3/9 | -5.51 | — | +19% |
| NNOX | Nano-X Imaging Ltd. | 2/9 | -3.7 | — | +15.4% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
| HMC | HONDA MOTOR CO LTD | 6/9 | 2.79 | — | +19.9% |
| SONY | Sony Group Corp | 6/9 | 0.86 | — | +9% |
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
FAQ
Is GEHC financially healthy?
GE HealthCare Technologies Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the grey zone.
Does GEHC pay a dividend, and is it safe?
Yes. GE HealthCare Technologies Inc. pays a dividend yielding about 0.21% with a 3.1% payout ratio, rated “safe” for safety.
How profitable is GEHC?
In FY2025, GE HealthCare Technologies Inc. had a net margin of 10.1% and a return on equity of 20.1%.
Is GEHC overvalued or undervalued?
GE HealthCare Technologies Inc. trades at about 15.9× trailing earnings — below its 10-year norm (10-year range 16.5×–24.2×, median 20.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for GEHC?
The average Wall-Street price target for GE HealthCare Technologies Inc. is $82.50, about 14.1% above the recent price, from 18 analysts (consensus: buy).
Is GEHC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on GE HealthCare Technologies Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the grey zone, a P/E of about 14.4×, a dividend yield of 0.21%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.